Prof. Dr. Fatih Teker

1996–2002 — Ondokuz Mayıs University Faculty of Medicine, medical education.

2005–2010 — Istanbul Taksim Training and Research Hospital, Internal Medicine residency.

2011–2014 — Ondokuz Mayıs University Faculty of Medicine, Medical Oncology fellowship.

Since 2024 — Liv Hospital Gaziantep.

2018–2024 — Gaziantep University Faculty of Medicine, Professor and Head of Medical Oncology.

2017–2018 — Kocaeli State Hospital, Associate Professor and physician responsible for Medical Oncology.

2015–2017 — Diyarbakır Gazi Yaşargil Training and Research Hospital, Associate Professor and Internal Medicine training coordinator.

2011 — Rotterdam University, Netherlands, research fellow.

2003–2004 — Turkish Armed Forces, military physician, Sarıkamış.

2002–2003 — General practitioner.

Breast, lung and gastrointestinal cancers

Gynecologic and urogenital cancers

Supportive care

Targeted therapies and immunotherapy

Teker F, Demirag G, Erdem D, Kemal Y, Yucel I. Quality of life in colorectal cancer patients during chemotherapy in the era of monoclonal antibody therapies. J BUON. 2015;20(2):443–451. PubMed: 26011334.

Teker F, Yilmaz B, Kemal Y, Kut E, Yucel I. Efficacy and safety of docetaxel or epirubicin, combined with cisplatin and fluorouracil (DCF and ECF), regimens as first line chemotherapy for advanced gastric cancer: a retrospective analysis from Turkey. Asian Pac J Cancer Prev. 2014;15(16):6727–6732. DOI: 10.7314/APJCP.2014.15.16.6727.